Craft

Aesthetic Medical International Holdings

Stock Price

$0.4

2024-07-22

Market Capitalization

$15.9 M

2024-07-22

Revenue

¥722.9 M

FY, 2025

Aesthetic Medical International Holdings Summary

Company Summary

Overview
Aesthetic Medical International Holdings Group (formerly known as Shenzhen Pengcheng Clinic) is a holdings company operating through its hospitals (Shenzhen Pengai, Pengcheng Hospital, and Chongqing Pengai) providing aesthetic medical services. The company provides one-stop aesthetic service offerings including surgical aesthetic treatments such as eye surgery, rhinoplasty, breast augmentation and liposuction; non-surgical aesthetic treatments that comprise minimally invasive treatments and energy-based treatments as laser, ultrasound, and ultraviolet light treatments; and other aesthetic services such as cosmetic dentistry and general medical services.
Type
Public
Status
Active
Founded
1997
HQ
Shenzhen Shi, CN | view all locations
Website
http://www.pengai.com.cn/
Cybersecurity rating
Sectors

Key People

  • Zhou Pengwu, Chairman of the Board of Directors and Chief Executive Officer

    • Ding Wenting, Vice-chairwoman of the Board of Directors and Chief Marketing Officer

      • Hu Qing, Chief Operating Officer

        • Zhou Yitao, Chief Medical Technique Officer

          Operating MetricsView all

          Surgical Treatments

          28K
          14.1%

          Q2, 2019

          Average Spending per Non-surgical Procedure

          ¥1.4K
          9.4%

          Q2, 2019

          Doctors

          203
          1.5%

          Q2, 2019

          LocationsView all

          1 location detected

          • Shenzhen Shi, Guangdong Sheng HQ

            China

            1122 Nanshan Ave, Nan You, Nanshan Qu

          Aesthetic Medical International Holdings Financials

          Summary Financials

          Revenue (FY, 2025)
          ¥722.9M
          Gross profit (FY, 2025)
          ¥393.1M
          Net income (FY, 2025)
          (¥54.1M)
          Cash (FY, 2025)
          ¥60.3M
          EBIT (FY, 2025)
          (¥16.1M)
          Enterprise value
          $99.9M

          Footer menu